Suppr超能文献

委内瑞拉一家医院中失代偿性心力衰竭患者护理质量的演变

Evolution of the Quality of Care in Patients with Decompensated Heart Failure in a Venezuelan Hospital.

作者信息

Torres Yaneth, Benitez Daniel, Morillo Zenaida, Salazar Juan, Contreras-Velasquez Julio, Bermudez Valmore

机构信息

Servicio de Cardiología, Hospital General del Sur, Maracaibo 4001, Venezuela.

Instituto de Investigaciones de Enfermedades Cardiovasculares de La Universidad del Zulia (IECLUZ), Maracaibo 4001, Venezuela.

出版信息

J Clin Med. 2025 Jan 20;14(2):644. doi: 10.3390/jcm14020644.

Abstract

Several parameters have been proposed for the objective measurement of the quality of care (QoC) and breaches of care in patients with heart failure (HF). Therefore, the objective of this study was to evaluate the measures of QoC in inpatients with decompensated HF in the cardiology department of a tertiary Venezuelan hospital. : An observational, descriptive, ambispective study was conducted with adults of all genders diagnosed with decompensated HF between 2022 and 2024. Sociodemographic, clinical, and therapeutic variables were assessed, as well as psychobiologic habits, measures of QoC, readmissions, and in-hospital mortality within the first 6 months of care. : Among the 131 subjects evaluated, the average age was 63.6 ± 14.1 years, with 58% (n = 76) being male. Among the in-hospital measures of QoC, the most common was the programming for follow-up consultations (98.5%; n = 129), followed by the prescription of beta-blockers (90.1%; n = 118). An upwards trend was also observed in the later years regarding the frequency of left ventricle ejection fraction (LVEF) assessment ( < 0.001), and the use of iSGLT2 ( = 0.03). During follow-up, 36.6% of the patients died within 6 months, with those in NYHA class IV showing a higher probability of death (OR: 3.84; CI95%: 0.89-16.55; 0.04). : The in-hospital measures for QoC in this population were similar to those in previous reports, with LVEF assessment and iSGLT2 prescription showing a particularly significant increase in recent years.

摘要

已经提出了几个参数用于客观衡量心力衰竭(HF)患者的护理质量(QoC)和护理缺陷。因此,本研究的目的是评估委内瑞拉一家三级医院心内科失代偿性HF住院患者的QoC指标。:对2022年至2024年间诊断为失代偿性HF的各性别成年人进行了一项观察性、描述性、双向性研究。评估了社会人口统计学、临床和治疗变量,以及心理生物学习惯、QoC指标、再入院情况和护理前6个月内的院内死亡率。:在评估的131名受试者中,平均年龄为63.6±14.1岁,58%(n = 76)为男性。在院内QoC指标中,最常见的是安排随访咨询(98.5%;n = 129),其次是β受体阻滞剂处方(90.1%;n = 118)。近年来,左心室射血分数(LVEF)评估频率(<0.001)和钠-葡萄糖协同转运蛋白2抑制剂(iSGLT2)的使用(=0.03)也呈上升趋势。随访期间,36.6%的患者在6个月内死亡,纽约心脏协会(NYHA)IV级患者的死亡概率更高(OR:3.84;95%CI:0.89 - 16.55;P = 0.04)。:该人群的院内QoC指标与以往报告相似,LVEF评估和iSGLT2处方近年来尤其显著增加。

相似文献

2
The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.
Front Cardiovasc Med. 2021 Mar 5;8:618398. doi: 10.3389/fcvm.2021.618398. eCollection 2021.
6
Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry.
EClinicalMedicine. 2025 Jan 10;80:103031. doi: 10.1016/j.eclinm.2024.103031. eCollection 2025 Feb.
7
Gender Differences in Left Ventricular Ejection Fraction and Outcomes Among Patients Hospitalized for Acute Decompensated Heart Failure.
Am J Cardiol. 2017 May 15;119(10):1623-1630. doi: 10.1016/j.amjcard.2017.02.012. Epub 2017 Mar 1.
8
9
Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective.
JACC Heart Fail. 2025 Feb;13(2):229-247. doi: 10.1016/j.jchf.2024.09.009. Epub 2024 Nov 6.
10
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

本文引用的文献

1
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.
J Card Fail. 2025 Jan;31(1):66-116. doi: 10.1016/j.cardfail.2024.07.001. Epub 2024 Sep 24.
2
Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs.
JAMA Cardiol. 2024 Nov 1;9(11):1029-1038. doi: 10.1001/jamacardio.2024.2969.
4
Global epidemiology of heart failure.
Nat Rev Cardiol. 2024 Oct;21(10):717-734. doi: 10.1038/s41569-024-01046-6. Epub 2024 Jun 26.
5
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021.
BMC Cardiovasc Disord. 2024 May 30;24(1):285. doi: 10.1186/s12872-024-03961-5.
6
2024 update in heart failure.
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.
7
Epidemiology and Burden of Heart Failure in Asia.
JACC Asia. 2024 Mar 19;4(4):249-264. doi: 10.1016/j.jacasi.2024.01.013. eCollection 2024 Apr.
8
Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.
ESC Heart Fail. 2023 Oct;10(5):3152-3163. doi: 10.1002/ehf2.14468. Epub 2023 Aug 30.
9
Global Variations in Heart Failure Etiology, Management, and Outcomes.
JAMA. 2023 May 16;329(19):1650-1661. doi: 10.1001/jama.2023.5942.
10
Treatment Strategies of Improving Quality of Care in Patients With Heart Failure.
Korean Circ J. 2023 May;53(5):294-312. doi: 10.4070/kcj.2023.0024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验